Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Genotypic determinants of fluoroquinolone and macrolide resistance in Neisseria gonorrhoeae.

Hall CL, Harrison MA, Pond MJ, Chow C, Harding-Esch EM, Sadiq ST.

Sex Health. 2019 Aug 1. doi: 10.1071/SH18225. [Epub ahead of print]

PMID:
31366421
2.
3.

Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection.

Harrison MA, Harding-Esch EM, Marks M, Pond MJ, Butcher R, Solomon AW, Zhou L, Tan N, Nori AV, Kako H, Sokana O, Mabey DCW, Sadiq ST.

Sex Transm Infect. 2019 Apr 13. pii: sextrans-2018-053938. doi: 10.1136/sextrans-2018-053938. [Epub ahead of print]

4.

Completing Baseline Mapping of Trachoma in Uganda: Results of 14 Population-Based Prevalence Surveys Conducted in 2014 and 2018.

Baayenda G, Mugume F, Turyaguma P, Tukahebwa EM, Binagwa B, Onapa A, Agunyo S, Osilo MK, French MD, Thuo W, Rotondo LA, Renneker K, Willis R, Bakhtiari A, Harding-Esch EM, Solomon AW, Ngondi JM.

Ophthalmic Epidemiol. 2018 Dec;25(sup1):162-170. doi: 10.1080/09286586.2018.1546879.

5.

'Test n Treat' (TnT): a cluster randomized feasibility trial of on-site rapid Chlamydia trachomatis tests and treatment in ethnically diverse, sexually active teenagers attending technical colleges.

Oakeshott P, Kerry-Barnard S, Fleming C, Phillips R, Drennan VM, Adams EJ, Majewska W, Harding-Esch EM, Cousins EC, Planche T, Green A, Bartholomew RI, Sadiq ST, Reid F.

Clin Microbiol Infect. 2019 Jul;25(7):865-871. doi: 10.1016/j.cmi.2018.10.019. Epub 2018 Nov 1.

6.

Health-related quality of life and psychosocial impacts of a diagnosis of non-specific genital infection in symptomatic heterosexual men attending UK sexual health clinics: a feasibility study.

Hill-Tout R, Harding-Esch EM, Pacho A, Furegato M, Fuller SS, Sadiq ST.

BMJ Open. 2018 Jun 30;8(6):e018213. doi: 10.1136/bmjopen-2017-018213.

7.

Diagnostic accuracy of a prototype rapid chlamydia and gonorrhoea recombinase polymerase amplification assay: a multicentre cross-sectional preclinical evaluation.

Harding-Esch EM, Fuller SS, Chow SC, Nori AV, Harrison MA, Parker M, Piepenburg O, Forrest MS, Brooks DG, Patel R, Hay PE, Fearnley N, Pond MJ, Dunbar JK, Butcher PD, Planche T, Lowndes CM, Sadiq ST.

Clin Microbiol Infect. 2019 Mar;25(3):380.e1-380.e7. doi: 10.1016/j.cmi.2018.06.003. Epub 2018 Jun 12.

8.

Detection of Chlamydia trachomatis in rectal specimens in women and its association with anal intercourse: a systematic review and meta-analysis.

Chandra NL, Broad C, Folkard K, Town K, Harding-Esch EM, Woodhall SC, Saunders JM, Sadiq ST, Dunbar JK.

Sex Transm Infect. 2018 Aug;94(5):320-326. doi: 10.1136/sextrans-2017-053161. Epub 2018 Feb 3.

9.

A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic Accuracy.

Harding-Esch EM, Cousins EC, Chow SC, Phillips LT, Hall CL, Cooper N, Fuller SS, Nori AV, Patel R, Thomas-William S, Whitlock G, Edwards SJE, Green M, Clarkson J, Arlett B, Dunbar JK, Lowndes CM, Sadiq ST.

EBioMedicine. 2018 Feb;28:120-127. doi: 10.1016/j.ebiom.2017.12.029. Epub 2018 Jan 10.

10.

The eSexual Health Clinic system for management, prevention, and control of sexually transmitted infections: exploratory studies in people testing for Chlamydia trachomatis.

Estcourt CS, Gibbs J, Sutcliffe LJ, Gkatzidou V, Tickle L, Hone K, Aicken C, Lowndes CM, Harding-Esch EM, Eaton S, Oakeshott P, Szczepura A, Ashcroft RE, Copas A, Nettleship A, Sadiq ST, Sonnenberg P.

Lancet Public Health. 2017 Apr;2(4):e182-e190. doi: 10.1016/S2468-2667(17)30034-8. Epub 2017 Mar 18.

11.

Using the eSexual Health Clinic to access chlamydia treatment and care via the internet: a qualitative interview study.

Aicken CRH, Sutcliffe LJ, Gibbs J, Tickle LJ, Hone K, Harding-Esch EM, Mercer CH, Sonnenberg P, Sadiq ST, Estcourt CS, Shahmanesh M.

Sex Transm Infect. 2018 Jun;94(4):241-247. doi: 10.1136/sextrans-2017-053227. Epub 2017 Oct 7.

12.

Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal.

Harding-Esch EM, Kadimpeul J, Sarr B, Sane A, Badji S, Laye M, Sillah A, Burr SE, MacLeod D, Last AR, Holland MJ, Mabey DC, Bailey RL.

BMC Public Health. 2017 Jul 26;18(1):62. doi: 10.1186/s12889-017-4605-0. Erratum in: BMC Public Health. 2017 Sep 22;17 (1):736.

13.

Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control.

Bojang E, Jafali J, Perreten V, Hart J, Harding-Esch EM, Sillah A, Mabey DC, Holland MJ, Bailey RL, Roca A, Burr SE.

BMC Microbiol. 2017 Mar 28;17(1):75. doi: 10.1186/s12866-017-0982-x.

14.

Impact of deploying multiple point-of-care tests with a 'sample first' approach on a sexual health clinical care pathway. A service evaluation.

Harding-Esch EM, Nori AV, Hegazi A, Pond MJ, Okolo O, Nardone A, Lowndes CM, Hay P, Sadiq ST.

Sex Transm Infect. 2017 Sep;93(6):424-429. doi: 10.1136/sextrans-2016-052988. Epub 2017 Feb 3.

15.

Self-sampling and self-testing for STIs and HIV: the case for consistent nomenclature.

Harding-Esch EM, Hollis E, Mohammed H, Saunders JM.

Sex Transm Infect. 2017 Mar;93(2):445-448. doi: 10.1136/sextrans-2016-052841. Epub 2016 Nov 3. No abstract available.

16.

Cross-Sectional Surveys of the Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination Been Reached?

Burr SE, Sillah A, Sanou AS, Wadagni AC, Hart J, Harding-Esch EM, Kanyi S, Bailey RL.

PLoS Negl Trop Dis. 2016 Sep 19;10(9):e0004906. doi: 10.1371/journal.pntd.0004906. eCollection 2016 Sep.

17.

The eClinical Care Pathway Framework: a novel structure for creation of online complex clinical care pathways and its application in the management of sexually transmitted infections.

Gibbs J, Sutcliffe LJ, Gkatzidou V, Hone K, Ashcroft RE, Harding-Esch EM, Lowndes CM, Sadiq ST, Sonnenberg P, Estcourt CS.

BMC Med Inform Decis Mak. 2016 Jul 22;16:98. doi: 10.1186/s12911-016-0338-8.

18.

Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control.

Burr SE, Hart J, Edwards T, Harding-Esch EM, Holland MJ, Mabey DC, Sillah A, Bailey RL.

BMC Public Health. 2014 Nov 18;14:1176. doi: 10.1186/1471-2458-14-1176.

19.

Non-participation during azithromycin mass treatment for trachoma in The Gambia: heterogeneity and risk factors.

Edwards T, Allen E, Harding-Esch EM, Hart J, Burr SE, Holland MJ, Sillah A, West SK, Mabey D, Bailey R.

PLoS Negl Trop Dis. 2014 Aug 28;8(8):e3098. doi: 10.1371/journal.pntd.0003098. eCollection 2014 Aug.

20.

Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia.

Burr SE, Milne S, Jafali J, Bojang E, Rajasekhar M, Hart J, Harding-Esch EM, Holland MJ, Mabey DC, Sillah A, Bailey RL, Roca A.

Bull World Health Organ. 2014 Jul 1;92(7):490-8. doi: 10.2471/BLT.13.133462. Epub 2014 Apr 29.

21.

Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.

Last AR, Burr SE, Weiss HA, Harding-Esch EM, Cassama E, Nabicassa M, Mabey DC, Holland MJ, Bailey RL.

PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2900. doi: 10.1371/journal.pntd.0002900. eCollection 2014 Jun.

22.

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.

Roberts CH, Molina S, Makalo P, Joof H, Harding-Esch EM, Burr SE, Mabey DC, Bailey RL, Burton MJ, Holland MJ.

PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2744. doi: 10.1371/journal.pntd.0002744. eCollection 2014 Mar.

23.

Effect of azithromycin mass drug administration for trachoma on spleen rates in Gambian children.

Hart JD, Edwards T, Burr SE, Harding-Esch EM, Takaoka K, Holland MJ, Sillah A, Mabey DC, Bailey RL.

Trop Med Int Health. 2014 Feb;19(2):207-11. doi: 10.1111/tmi.12234. Epub 2014 Jan 17.

24.

Follicular trachoma and trichiasis prevalence in an urban community in The Gambia, West Africa: is there a need to include urban areas in national trachoma surveillance?

Quicke E, Sillah A, Harding-Esch EM, Last A, Joof H, Makalo P, Bailey RL, Burr SE.

Trop Med Int Health. 2013 Nov;18(11):1344-52. doi: 10.1111/tmi.12182. Epub 2013 Sep 6.

25.

Association between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia.

Burr SE, Hart JD, Edwards T, Baldeh I, Bojang E, Harding-Esch EM, Holland MJ, Lietman TM, West SK, Mabey DC, Sillah A, Bailey RL.

PLoS Negl Trop Dis. 2013 Jul 25;7(7):e2347. doi: 10.1371/journal.pntd.0002347. Print 2013.

26.

Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.

Harding-Esch EM, Sillah A, Edwards T, Burr SE, Hart JD, Joof H, Laye M, Makalo P, Manjang A, Molina S, Sarr-Sissoho I, Quinn TC, Lietman T, Holland MJ, Mabey D, West SK, Bailey R; Partnership for Rapid Elimination of Trachoma (PRET) study group.

PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2115. doi: 10.1371/journal.pntd.0002115. Print 2013. Erratum in: PLoS Negl Trop Dis. 2013 Jun;7(6). doi:10.1371/annotation/0bae8b34-5ae7-4044-a071-8d88d520a01b.

27.

A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles.

Solomon AW, Engels D, Bailey RL, Blake IM, Brooker S, Chen JX, Chen JH, Churcher TS, Drakeley CJ, Edwards T, Fenwick A, French M, Gabrielli AF, Grassly NC, Harding-Esch EM, Holland MJ, Koukounari A, Lammie PJ, Leslie J, Mabey DC, Rhajaoui M, Secor WE, Stothard JR, Wei H, Willingham AL, Zhou XN, Peeling RW.

PLoS Negl Trop Dis. 2012;6(7):e1746. doi: 10.1371/journal.pntd.0001746. Epub 2012 Jul 31. Review. No abstract available.

28.

Diagnostic accuracy of a prototype point-of-care test for ocular Chlamydia trachomatis under field conditions in The Gambia and Senegal.

Harding-Esch EM, Holland MJ, Schémann JF, Molina S, Sarr I, Andreasen AA, Roberts Ch, Sillah A, Sarr B, Harding EF, Edwards T, Bailey RL, Mabey DC.

PLoS Negl Trop Dis. 2011 Aug;5(8):e1234. doi: 10.1371/journal.pntd.0001234. Epub 2011 Aug 2.

29.

Mapping the global distribution of trachoma: why an updated atlas is needed.

Smith JL, Haddad D, Polack S, Harding-Esch EM, Hooper PJ, Mabey DC, Solomon AW, Brooker S.

PLoS Negl Trop Dis. 2011 Jun;5(6):e973. doi: 10.1371/journal.pntd.0000973. Epub 2011 Jun 28. Review. No abstract available.

30.

Incremental cost of conducting population-based prevalence surveys for a neglected tropical disease: the example of trachoma in 8 national programs.

Chen C, Cromwell EA, King JD, Mosher A, Harding-Esch EM, Ngondi JM, Emerson PM.

PLoS Negl Trop Dis. 2011 Mar 8;5(3):e979. doi: 10.1371/journal.pntd.0000979.

31.

Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial.

Harding-Esch EM, Edwards T, Mkocha H, Munoz B, Holland MJ, Burr SE, Sillah A, Gaydos CA, Stare D, Mabey DC, Bailey RL, West SK; PRET Partnership.

PLoS Negl Trop Dis. 2010 Nov 2;4(11):e861. doi: 10.1371/journal.pntd.0000861.

32.

Mass treatment with azithromycin for trachoma control: participation clusters in households.

Ssemanda EN, Munoz B, Harding-Esch EM, Edwards T, Mkocha H, Bailey RL, Sillah A, Stare D, Mabey DC, West SK; PRET Project Team.

PLoS Negl Trop Dis. 2010 Oct 5;4(10). pii: e838. doi: 10.1371/journal.pntd.0000838.

33.

Epidemiology and control of trachoma: systematic review.

Hu VH, Harding-Esch EM, Burton MJ, Bailey RL, Kadimpeul J, Mabey DC.

Trop Med Int Health. 2010 Jun;15(6):673-91. doi: 10.1111/j.1365-3156.2010.02521.x. Epub 2010 Apr 4. Review.

34.

Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?

Harding-Esch EM, Edwards T, Sillah A, Sarr I, Roberts CH, Snell P, Aryee E, Molina S, Holland MJ, Mabey DC, Bailey RL.

PLoS Negl Trop Dis. 2009 Dec 22;3(12):e573. doi: 10.1371/journal.pntd.0000573.

35.

Risk factors for active trachoma in The Gambia.

Harding-Esch EM, Edwards T, Sillah A, Sarr-Sissoho I, Aryee EA, Snell P, Holland MJ, Mabey DC, Bailey RL.

Trans R Soc Trop Med Hyg. 2008 Dec;102(12):1255-62. doi: 10.1016/j.trstmh.2008.04.022. Epub 2008 May 27.

36.

Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin.

Edwards T, Harding-Esch EM, Hailu G, Andreason A, Mabey DC, Todd J, Cumberland P.

Trop Med Int Health. 2008 Apr;13(4):556-65. doi: 10.1111/j.1365-3156.2008.02034.x. Epub 2008 Feb 14.

37.

Prevalence of Chlamydia trachomatis infection among low- and high-risk Filipino women and performance of Chlamydia rapid tests in resource-limited settings.

Saison F, Mahilum-Tapay L, Michel CE, Buttress ND, Nadala EC Jr, Magbanua JP, Harding-Esch EM, Villaruel MO, Canong L, Celis RL, Lee HH.

J Clin Microbiol. 2007 Dec;45(12):4011-7. Epub 2007 Oct 17.

Supplemental Content

Loading ...
Support Center